期刊文献+

妊娠晚期药物干预性引产与剖宫产率的临床观察 被引量:1

原文传递
导出
摘要 目的:观察妊娠晚期药物干预性引产与剖宫产率。方法:对药物引产者389例与自然分娩320例两组分娩方式、剖宫产指征和对母婴的影响进行统计学分析。结果:治疗组剖宫产率为38.3%,明显高于对照组的17.8%。结论:过早药物干预性引产也是导致剖宫产率增高的原因之一。对妊娠晚期在无任何产科并发症,胎儿、胎盘功能及羊水状况均正常情况下,最好等待自然分娩,不要过早干预。
出处 《青海医药杂志》 2013年第6期18-19,共2页 Qinghai Medical Journal
  • 相关文献

参考文献2

二级参考文献11

  • 1[1]Zhanf J, Yancey MK, Henderson CE. US National trends in labor induction,1989-1998. J Reprod Med ,2002,47:120-124.
  • 2[2]Bishop EM. Pelvic scoting for elective induction. Obstet Gynecol, 1964,24:266-268.
  • 3[3]Stitely ML and Statin AJ. Cervical ripening agents and uterine stimulants. Clin Obstet Gynecol, 2002,45(1):114-124.
  • 4[4]Blair FC, Tassone SA, Pearman CR et al. Initiation of labor using a sustained-release PGE2 vaginal insert.Experience at a community hospital. J Reprod Med,1997,43:408-412.
  • 5[5]Kelly AJ, Kavanagh J, Thomas J. Vaginal prostaglandin (PGE2 and PGF2a) for induction of labour at term. Cochrane Database Syst Rev,2001,(2):CD003101.
  • 6[6]Hadi HA. Cervical ripening and labor induction: clinical guidelines. Clin Obstet Gynecol, 2000,43:524-536.
  • 7[7]Hofmeyr GJ, Gulmezoglu AM. Vaginal misoprostol for cervical ripening and induction of labor. Cochrone Database Syst Rev, 2003,(1):CD00941.
  • 8[8]American College of Obstetricians and Gynecologists. Response to Searle's drug warning on misoprostol. ACOG committee opinion no.248. Washington. DC: American College of Obstetricians and Gynecologists, 2000,159.
  • 9[9]Sanchez-Ramos L, Kaunitz AM, Delke L. Labor induction with 25μg versus 50 μg Intravaginal misoprostol: A systematic review. Obstet Gynecol, 2002,99:145-151.
  • 10[10]Kavanagh J, Kelly AL, and Thomas J. Hyaluronidase for cervical priming and induction of labor. Cochrone Database Syst Rev,2001,(2):CD003097.

共引文献91

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部